Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi pasteur msd ltd - measles virus - enders edmonston strain mumps virus - jerylynn strain rubella virus - wistar ra27/3 strain - 0.5ml millilitre

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - methylprednisolone sodium succinate, quantity: 1.326 g (equivalent: methylprednisolone, qty 1 g) - injection, powder for - excipient ingredients: monobasic sodium phosphate monohydrate; dibasic sodium phosphate; sodium hydroxide - when oral therapy is not feasible and the strength, dosage form and route of administration of the drug reasonably lend the preparation to the treatment of the condition, solu-medrol powder for injection is indicated only for intravenous or intramuscular use in the following conditions:,endocrine disorders,? primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogues may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance).,? acute adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; mineralocorticoid supplementation may be necessary, particularly when synthetic analogues are used).,? preoperatively and in the event of serious trauma or illness, in patients with known adrenal insufficiency or when adrenocortical reserve is doubtful.,? shock unresponsive to conventional therapy if adrenocortical insufficiency exists or is suspected.,? c

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi pasteur msd ltd - measles virus live attenuated derived from the edmonston b strain mumps virus - jerylynn strain rubella virus (wistar ra 27/3 strain) live attenuated - pdr+solv for soln for inj - %v/v

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi pasteur msd ltd - measles virus - enders edmonston strain mumps virus - jerylynn strain rubella virus - wistar ra27/3 strain - 0.5ml millilitre

United Kingdom - English - VMD (Veterinary Medicines Directorate)

zoetis uk limited - porcine respiratory and reproductive syndrome virus - lyophilisate and solvent for solution for injection - live viral vaccine - pigs

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - vinblastine sulfate, quantity: 1 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride - used in the treatment of hodgkins' disease (stages iii and iv) in combination therapy (with adriamycin, bleomycin and dacarbazine as abvd) and in the treatment of advanced testicular carcinoma (with cisplatin and bleomycin). in the palliative treatment of lymphocytic lymphoma, histiocytic lymphoma, kaposi's sarcoma and histiocytosis x. advanced stages of mycosis fungoides. may be used in the treatment of choriocarcinoma resistant to other chemotherapeutic agents; carcinoma of the breast, unresponsive to appropriate endocrine surgery and hormonal therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - live varicella vaccine, quantity: 4000 pfu/ml; isoleucine, quantity: 0.355 mg - injection, powder for - excipient ingredients: lactose; mannitol; sorbitol; threonine; serine; proline; glycine; alanine; valine; methionine; leucine; tyrosine; phenylalanine; tryptophan; lysine hydrochloride; histidine; arginine - varilrix hsa-free is indicated for active immunisation against varicella of healthy subjects from 9 months of age. groups who would particularly benefit from vaccination include: non-immune adults, especially those in at-risk occupations such as health care workers, teachers and workers in children's day-care centres. non-immune parents of young children. non-immune household contacts, both adults and children, of immunocompromised patients with no history of the disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - live varicella vaccine, quantity: 4000 pfu/ml - injection, powder for - excipient ingredients: lactose; mannitol; sorbitol; threonine; serine; proline; glycine; alanine; valine; methionine; isoleucine; leucine; tyrosine; phenylalanine; tryptophan; lysine hydrochloride; histidine; arginine - varilrix hsa-free is indicated for active immunisation against varicella of healthy subjects from 9 months of age. groups who would particularly benefit from vaccination include: non-immune adults, especially those in at-risk occupations such as health care workers, teachers and workers in children's day-care centres. non-immune parents of young children. non-immune household contacts, both adults and children, of immuncompromised patients with no history of the disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - brown snake antivenom, quantity: 1000 u - injection, concentrated - excipient ingredients: phenol; sodium chloride; water for injections - for the treatment of patients who exhibit manifestations of systemic envenoming following a bite by a snake of the genus pseudonaja. this genus includes the eastern brown snake, the dugite and the gwardar (western brown snake).

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - box jellyfish antivenom, quantity: 20000 u - injection, solution - excipient ingredients: phenol; sodium chloride; water for injections - for the treatment of patients who exhibit manifestations of systemic envenoming or who have extensive local involvement causing extreme pain which does not respond to routine analgesic therapy.